{"id":"https://openalex.org/W4366278447","doi":"https://doi.org/10.1038/s41598-023-33417-3","title":"Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus","display_name":"Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus","publication_year":2023,"publication_date":"2023-04-18","ids":{"openalex":"https://openalex.org/W4366278447","doi":"https://doi.org/10.1038/s41598-023-33417-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/37072577","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10113266"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-023-33417-3","doi":"https://doi.org/10.1038/s41598-023-33417-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-023-33417-3","pdf_url":"https://www.nature.com/articles/s41598-023-33417-3.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-023-33417-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084766933","display_name":"Rania Zekry","orcid":"https://orcid.org/0000-0001-9497-1091","observed_orcids":["https://orcid.org/0000-0001-9497-1091"]},"institutions":[{"id":"https://openalex.org/I169744251","display_name":"Damanhour University","ror":"https://ror.org/03svthf85","country_code":"EG","type":"education","lineage":["https://openalex.org/I169744251"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Rania Zekry","raw_affiliation_strings":["Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt","institution_ids":["https://openalex.org/I169744251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081923281","display_name":"Gamal A. Omran","orcid":"https://orcid.org/0000-0002-1609-8802","observed_orcids":["https://orcid.org/0000-0002-1609-8802"]},"institutions":[{"id":"https://openalex.org/I169744251","display_name":"Damanhour University","ror":"https://ror.org/03svthf85","country_code":"EG","type":"education","lineage":["https://openalex.org/I169744251"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Gamal A. Omran","raw_affiliation_strings":["Department of Biochemistry, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt","institution_ids":["https://openalex.org/I169744251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036384027","display_name":"Nashwa M. El-Gharbawy","orcid":"https://orcid.org/0000-0002-2551-0731","observed_orcids":["https://orcid.org/0000-0002-2551-0731"]},"institutions":[{"id":"https://openalex.org/I21376657","display_name":"Tanta University","ror":"https://ror.org/016jp5b92","country_code":"EG","type":"education","lineage":["https://openalex.org/I21376657"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Nashwa M. El-Gharbawy","raw_affiliation_strings":["Diabetes and Endocrinology Unit, Department of Internal Medicine, Tanta University, Tanta, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes and Endocrinology Unit, Department of Internal Medicine, Tanta University, Tanta, Egypt","institution_ids":["https://openalex.org/I21376657"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022051535","display_name":"Rehab H. Werida","orcid":"https://orcid.org/0000-0002-5983-3993","observed_orcids":["https://orcid.org/0000-0002-5983-3993"]},"institutions":[{"id":"https://openalex.org/I169744251","display_name":"Damanhour University","ror":"https://ror.org/03svthf85","country_code":"EG","type":"education","lineage":["https://openalex.org/I169744251"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"Rehab H. Werida","raw_affiliation_strings":["Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt. rehabwrieda@pharm.dmu.edu.eg","Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt"],"raw_orcid":"https://orcid.org/0000-0002-5983-3993","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt. rehabwrieda@pharm.dmu.edu.eg","institution_ids":["https://openalex.org/I169744251"]},{"raw_affiliation_string":"Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt","institution_ids":["https://openalex.org/I169744251"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5022051535"],"corresponding_institution_ids":["https://openalex.org/I169744251"],"apc_list":{"value":2390,"currency":"USD","value_usd":2390},"apc_paid":{"value":2390,"currency":"USD","value_usd":2390},"fwci":1.8588,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.85619006,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"13","issue":"1","first_page":"6302","last_page":"6302"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9810000061988831},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/insulin-regulated-aminopeptidase","display_name":"IRAP","score":0.9580000042915344},{"id":"https://openalex.org/keywords/il-34","display_name":"IL-34","score":0.968999981880188},{"id":"https://openalex.org/keywords/nt-probnp","display_name":"NT-proBNP","score":0.968999981880188},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9710000157356262},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9290000200271606},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8360000252723694},{"id":"https://openalex.org/keywords/homa-ir","display_name":"HOMA-IR","score":0.8379999995231628},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.9861675500869751},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.9493805170059204},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8318431377410889},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5997985601425171},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.597919762134552},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5688684582710266},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5310811400413513},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5277605056762695},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5014486312866211},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4975586235523224},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.47798794507980347},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.43154722452163696},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40008217096328735}],"mesh":[{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1038/s41598-023-33417-3","doi":"https://doi.org/10.1038/s41598-023-33417-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-023-33417-3","pdf_url":"https://www.nature.com/articles/s41598-023-33417-3.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10113266","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10113266","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10113266/pdf/41598_2023_Article_33417.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmid:37072577","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37072577","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:doaj.org/article:dbccf3ec1be6464991a8a755d870cd2f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dbccf3ec1be6464991a8a755d870cd2f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)","raw_type":"article"},{"id":"doi:10.60692/0m3ev-89383","doi":"https://doi.org/10.60692/0m3ev-89383","is_oa":true,"landing_page_url":"https://doi.org/10.60692/0m3ev-89383","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.60692/yxyga-eb660","doi":"https://doi.org/10.60692/yxyga-eb660","is_oa":true,"landing_page_url":"https://doi.org/10.60692/yxyga-eb660","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.1038/s41598-023-33417-3","doi":"https://doi.org/10.1038/s41598-023-33417-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-023-33417-3","pdf_url":"https://www.nature.com/articles/s41598-023-33417-3.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321655","display_name":"Science and Technology Development Fund","ror":"https://ror.org/044vr6g03"},{"id":"https://openalex.org/F4320324798","display_name":"Tanta University","ror":"https://ror.org/016jp5b92"},{"id":"https://openalex.org/F7802773743","display_name":"Damanhour University","ror":"https://ror.org/03svthf85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4366278447.pdf","grobid_xml":"https://content.openalex.org/works/W4366278447.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1565799535","https://openalex.org/W1991412148","https://openalex.org/W2015191704","https://openalex.org/W2015314347","https://openalex.org/W2084662370","https://openalex.org/W2090610606","https://openalex.org/W2124620553","https://openalex.org/W2148328779","https://openalex.org/W2156600593","https://openalex.org/W2286842539","https://openalex.org/W2889071685","https://openalex.org/W2889465766","https://openalex.org/W2974260792","https://openalex.org/W2981475366","https://openalex.org/W2990049386","https://openalex.org/W3112760864","https://openalex.org/W3132840388","https://openalex.org/W3162860061","https://openalex.org/W3168021953","https://openalex.org/W3199771624","https://openalex.org/W3208377810","https://openalex.org/W4200161106","https://openalex.org/W4206443449","https://openalex.org/W4225369889"],"related_works":["https://openalex.org/W3081736462","https://openalex.org/W4399735106","https://openalex.org/W2388486195","https://openalex.org/W2959507542","https://openalex.org/W3130470410","https://openalex.org/W3006395478","https://openalex.org/W4409315262","https://openalex.org/W2318555642","https://openalex.org/W7162116692","https://openalex.org/W2387223007"],"abstract_inverted_index":{"Type":[0],"2":[1,62],"diabetes":[2],"mellitus":[3],"(T2DM)":[4],"is":[5,99,109,133],"one":[6],"of":[7,29,43,92,104,116,175],"the":[8,27,106,114,173],"most":[9],"common":[10],"diseases,":[11],"that":[12],"managed":[13],"by":[14],"several":[15],"medications":[16],"such":[17],"as":[18,40],"Glimepiride":[19,32,71,117,154,189],"and":[20,38,50,88,118,126,140,147,155,161,188],"Dapagliflozin.":[21],"This":[22,57,201],"study":[23,58],"aims":[24],"to":[25,68],"compare":[26],"effects":[28,115],"Dapagliflozin":[30,77,119,156,177],"versus":[31],"on":[33,120,183,193,205],"glycemic":[34,159],"control,":[35,160],"insulin":[36,44],"resistance,":[37],"biomarkers":[39],"(extracellular":[41],"domain":[42],"regulated":[45],"aminopeptidase)":[46],"IRAPe,":[47],"(interleukin-34)":[48],"IL-34,":[49,187],"(N-terminal":[51],"pro":[52],"b-type":[53],"natriuretic":[54],"peptide)":[55],"NT-proBNP.":[56,176],"included":[59],"60":[60],"type":[61],"diabetic":[63],"patients,":[64],"who":[65],"are":[66],"randomized":[67],"receive":[69],"either":[70],"4":[72],"mg/day":[73,79],"(group":[74,80],"1)":[75],"or":[76],"10":[78],"2).":[81],"Blood":[82],"samples":[83],"were":[84],"collected":[85],"at":[86],"baseline":[87],"after":[89],"3":[90,102],"months":[91,103],"treatment":[93],"for":[94,135,142],"biochemical":[95],"analysis.":[96],"Additionally,":[97],"HOMA-IR":[98,162],"calculated.":[100],"After":[101],"receiving":[105],"intervention,":[107],"there":[108],"no":[110,164],"significant":[111,134,165,181,191],"difference":[112,129,166],"between":[113,130,167],"FBG,":[121],"PPBG,":[122],"HbA1C%,":[123],"fasting":[124],"insulin,":[125],"HOMA-IR.":[127],"The":[128],"both":[131],"groups":[132],"IL-34":[136,194],"(p":[137,144,150],"=":[138,145,151],"0.002)":[139],"non-significant":[141],"IRAPe":[143,184],"0.12)":[146],"NT-Pro":[148],"BNP":[149],"0.68).":[152],"Both":[153,169],"significantly":[157,171],"improve":[158],"with":[163],"them.":[168],"drugs":[170],"improved":[172],"level":[174],"has":[178,190],"a":[179],"borderline":[180],"effect":[182,192],"but":[185,195],"not":[186,196],"IRAPe.":[197],"Clinical":[198],"Trial":[199],"Registration:":[200],"trial":[202],"was":[203],"registered":[204],"clinicaltrial.gov":[206],"(NCT04240171).":[207]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-20T00:00:00"}